Product Information
VUITY 1.25% EYE DROP is a brand product labeled by AbbVie Inc., priced at $31.3936 per ML under NDC 00074709804. Its NADAC has been published 227 times since Apr 20, 2022.
FDA first approved this application on Oct 28, 2021.
The High Outlier badge above means this manufacturer's average price in the Pilocarpine Hydrochloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
12.5 mg/mL
Manufacturer
AbbVie Inc.NDC
00074709804
Classification
Brand
Dosage Form
SOLUTION/ DROPS
Route
OPHTHALMIC
Effective Date
8/19/2026
Active Ingredients
PILOCARPINE HYDROCHLORIDEApproval Type
New Drug (NDA)
FDA Application
NDA214028FDA Approved
10/28/2021
On Market Since
10/28/2021
Pharmacological Classes
Price Statistics
The NADAC for VUITY 1.25% EYE DROP has been published 227 times since Apr 20, 2022, and over the history we have for it it has risen 11.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $31.3936 per ML |
|---|---|
| All-time high | $31.3936 (Aug 19, 2026) |
| All-time low | $28.1106 (Dec 20, 2023) |
| 52-week high | $31.3936 |
| 52-week low | $29.5760 |
| Median price | $29.5781 |
| Average price | $29.2902 |
| Largest weekly change | +5.0% (Jan 14, 2026) |
| Weeks tracked | 227 |
| Tracking since | Apr 20, 2022 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 25% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of VUITY 1.25% EYE DROP?
The current National Average Drug Acquisition Cost (NADAC) for VUITY 1.25% EYE DROP, manufactured by AbbVie Inc., is $31.3936 per ML (NDC 00074709804), effective Aug 19, 2026.
How has the price of VUITY 1.25% EYE DROP changed over time?
Over the history we have for it, the NADAC for VUITY 1.25% EYE DROP has risen 11.0%. It has been tracked across 227 weekly CMS publications since Apr 20, 2022.
What are the highest and lowest recorded NADAC prices for VUITY 1.25% EYE DROP?
Since Apr 20, 2022, the NADAC for VUITY 1.25% EYE DROP has ranged from a low of $28.1106 (Dec 20, 2023) to a high of $31.3936 (Aug 19, 2026), with a median of $29.5781 per ML.
Are there cheaper alternatives to VUITY 1.25% EYE DROP?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, VUITY 1.25% EYE DROP, is $23.3947 per ML — about 25% below VUITY 1.25% EYE DROP.
Who manufactures VUITY 1.25% EYE DROP?
VUITY 1.25% EYE DROP (NDC 00074709804) is labeled by AbbVie Inc., and CMS classifies it as a brand product.